Advanced Enzyme Technologies Limited has secured credit ratings from ICRA Limited for its banking facilities totaling ₹100 crore. The company announced the rating assignment to stock exchanges on February 13, 2026, in compliance with SEBI listing regulations.

Credit Rating Details

ICRA Limited assigned ratings across multiple banking instruments for Advanced Enzyme Technologies. The rating actions demonstrate the company's creditworthiness across different facility types.

Banking Facility Breakdown

The ₹40 crore fund-based cash credit facilities are distributed among multiple banking partners. Citibank N.A. provides ₹15 crore, HDFC Bank Limited contributes ₹12.50 crore, and proposed fund-based limits account for the remaining ₹12.50 crore.

For short-term non-fund based facilities worth ₹15 crore, HDFC Bank Limited provides ₹2.50 crore while proposed non-fund based limits constitute ₹12.50 crore. The unallocated limits of ₹45 crore carry dual ratings of [ICRA]AA-(Stable) for long-term and [ICRA]A1+ for short-term components.

Rating Surveillance and Conditions

ICRA Limited specified that the assigned ratings will require surveillance within one year from the rating communication date of February 13, 2026. The rating agency reserves the right to review or revise the ratings based on new information or changing circumstances that could impact the company's creditworthiness.

The ratings are specific to the current terms and conditions of the instruments. Any changes in terms or facility sizes would necessitate a rating review by ICRA. The company must inform ICRA about any defaults, delays in repayment, or significant developments affecting debt servicing capability.

Regulatory Compliance

Advanced Enzyme Technologies fulfilled its disclosure obligations under Regulation 30 of SEBI Listing Regulations by informing both BSE Limited and National Stock Exchange of India about the credit rating assignment. The company also uploaded the rating information on its website at www.advancedenzymes.com for stakeholder access.

Advanced Enzyme Technologies Ltd has announced a special window facility for shareholders holding physical shares to facilitate transfer and dematerialization processes. The company made this announcement on February 10, 2026, through newspaper publications and regulatory filings.

Regulatory Compliance and Communication

The company issued this intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Advanced Enzyme Technologies communicated this development to both major stock exchanges where its shares are listed.

Publication and Notification Process

The special window announcement was published in two prominent newspapers on February 10, 2026:

• Free Press Journal
• Navshakti

This publication serves to inform members holding physical shares about the availability of the special facility for transfer and dematerialization of their shareholdings.

Company Information

Advanced Enzyme Technologies Ltd operates from its registered office located at Sun Magnetics, 'A' wing, 5th Floor, LIC Service Road, Louiswadi, Thane (W)-400 604, India. The company maintains regular communication channels with shareholders through multiple contact methods including telephone, fax, and email services.

Documentation and Records

The company has enclosed copies of the newspaper publications with its regulatory filing, ensuring complete documentation of the public notice. Company Secretary and Head-Legal Sanjay Basantani signed the communication, which was digitally authenticated on February 10, 2026, at 14:38:10 +05'30'.

This initiative demonstrates the company's commitment to facilitating shareholder services and ensuring compliance with regulatory requirements for share transfer and dematerialization processes.